In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients

References

• Martin AR, Finlay, WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv 2015;12:889–900
   PubMed Web of Science ®Google Scholar
• Fink JB, Dhand R, Duarte AG, et al. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model. Am J Respir Crit Care Med 1996;154:382–387
   PubMed Web of Science ®Google Scholar
• Hess DR. Aerosol therapy during noninvasive ventilation or high-flow nasal cannula. Respir Care 2015;60:880–893
   PubMed Web of Science ®Google Scholar
• Nava S, Karakurt S, Rampulla C, et al. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study. Intensive Care Med 2001;27:1627–1635
   PubMed Web of Science ®Google Scholar
• Branconnier MP, Hess DR. Albuterol delivery during noninvasive ventilation. Respir Care, 2005;50:1649–1653
   PubMedGoogle Scholar
• Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulmon Drug Deliv 2012;25:63–78
   PubMed Web of Science ®Google Scholar
• Hassan A, Rabea H, Hussein RRS, et al. In vitro characterisation of aerosolised drug during non-invasive ventilation (NIV) [Abstract]. J Aerosol Med Pulmon Drug Deliv 2015;28:A-10 (P-014)
   Web of Science ®Google Scholar
• Ali AM, Abdelrahim MEA. Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innovat 2014;9:38–47
   Web of Science ®Google Scholar
• Ali AA, Ali AM. Optimization of propranolol HCl release kinetics from press coated sustained release tablets. Pharm Dev Technol 2013;18:1238–1246
   PubMed Web of Science ®Google Scholar
• Abdelrahman AA, Salem HF, Khallaf RA, et al. Modeling, optimization, and in vitro corneal permeation of chitosan-lomefloxacin HCl nanosuspension intended for ophthalmic delivery. J Pharm Innovat 2015;10:254–268
   Web of Science ®Google Scholar
• de Matas M, Shao Q, Silkstone VL, et al. Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks. J Pharm Sci 2007;96:3293–3303
   PubMed Web of Science ®Google Scholar
• de Matas M, Shao Q, Richardson CH, et al. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. Eur J Pharm Sci 2008;33:80–90
   PubMed Web of Science ®Google Scholar
• Sun Y, Peng Y, Chen Y, et al. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 2003;55:1201–1215
   PubMed Web of Science ®Google Scholar
• Chen Y, Thosar SS, Forbess RA, et al. Prediction of drug content and hardness of intact tablets using artificial neural network and near-infrared spectroscopy. Drug Dev Ind Pharm 2001;27:623–631
   PubMed Web of Science ®Google Scholar
• Hussain AS, Yu XQ, Johnson RD. Application of neural computing in pharmaceutical product development. Pharm Res 1991;8:1248–1252
   PubMed Web of Science ®Google Scholar
• Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62:966–972
   PubMed Web of Science ®Google Scholar
• Abdelrahim ME. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the next generation impactor. Pharm Dev Technol 2011;16:137–145
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). Chronic obstractive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2015 [cited 1 Apr 2015]. Available from: http://www.nice.org.uk/guidance/
   Google Scholar
• Plumb AP, Rowe RC, York P, et al. The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks. Eur J Pharm Sci 2002;16:281–288
   PubMed Web of Science ®Google Scholar
• Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992;34:311–315
   PubMed Web of Science ®Google Scholar
• Mazhar SH, Ismail NE, Newton DA, et al. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation. Br J Clin Pharmacol 2008;65:334–337
   PubMed Web of Science ®Google Scholar
• Ammari WGS. Evaluation of novel tool to ensure asthma and COPD patients use the approved inhalation technique when they use an inhaler. Clinical pharmacy studies investigating the impact of novel inhalation technique training devices and spacers on the inspiratory characteristics, disease control and quality of life of patients when using their inhalers. 2010, University of Bradford
   Google Scholar
• Terzano C. Pressurized metered dose inhalers and add-on devices. Pulm Pharmacol Ther 2001;14:351–366
   PubMed Web of Science ®Google Scholar
• Newman SP, Chan H-K. In vitro/in vivo comparisons in pulmonary drug delivery. J Aerosol Med Pulmon Drug Deliv 2008;21:77–84
   PubMed Web of Science ®Google Scholar
• Nahar K, Gupta N, Gauvin R, et al. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 2013;49:805–818
   PubMed Web of Science ®Google Scholar
• Byron PR, Hindle M, Lange CF, et al. In vivo–in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulmon Drug Deliv 2010;23:S-59–S-69
   PubMed Web of Science ®Google Scholar
• Fink JB, Dhand R, Grychowski J, et al. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 1999;159:63–68
   PubMed Web of Science ®Google Scholar
• Abdelrahim M, Plant P, Chrystyn H. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. Int J Pharm 2011;420:313–318
   PubMed Web of Science ®Google Scholar
• Abdelrahim M, Assi K, Chrystyn H. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol 2013;18:944–949
   PubMed Web of Science ®Google Scholar
• Abdelrahim ME, Chrystyn H. Aerodynamic characteristics of nebulized terbutaline sulphate using the next generation impactor (NGI) and CEN method. J Aerosol Med Pulm Drug Deliv 2009;22:19–28
   PubMed Web of Science ®Google Scholar
• Mohsenin V. Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions. Chest J 2001;120:1442–1447
   PubMed Web of Science ®Google Scholar
• Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv 2009;6:91–102
   PubMed Web of Science ®Google Scholar
• Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet 2004;43:349–360
   PubMed Web of Science ®Google Scholar
• Ahrens R, Lux C, Bahl T, et al. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995;96:288–294
   PubMed Web of Science ®Google Scholar
• Boe J, Dennis J, O'Driscoll B, et al. European Respiratory Society Guidelines on the use of nebulizers: guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. Eur Respir J 2001;18:228–242
   PubMed Web of Science ®Google Scholar